Article

A Managed Care Perspective: Treatment of Idiopathic Pulmonary Fibrosis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Clayton Irvine, PharmD, MBA, MS
Related Content
Chronic urticaria. | Image Credit: doucefleur - stock.adobe.com
August 15th 2025

Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?

Cameron Santoro
managed care cast banner
August 15th 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
Paper saying Medicaid eligibility | Image credit: Vitalii Vodolazskyi – stock.adobe.com
August 15th 2025

5 Key Takeaways on Medicaid Policy Changes From Savista’s Chief Strategy Officer

Hayden E. Klein Laxmi Patel
AJMC podcast banner
August 15th 2025

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

Hayden E. Klein Skylar Jeremias Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Older person eating healthy meal | Image Credit: Png - Video - Photo - stock.adobe.com
August 15th 2025

Low GNRI Score Associated With Higher All-Cause, Cardiovascular Mortality Rates in Older Adults With Osteoarthritis

Brooke McCormick
AJMC
August 15th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo